Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details)

v3.24.2.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk - Major vendors, combined
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Research and development expenditures          
Concentration          
Concentration Risk (as a percent) 35.00% 75.00% 36.00% 71.00%  
Accounts payable and accrued expense          
Concentration          
Concentration Risk (as a percent)     63.00%   53.00%